ArticleFrontiers in immunology2024
STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
Tianye Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papercites it